Industry · Manufacture of basic pharmaceutical products and pharmaceutical preparations
Manufacture of pharmaceuticals, medicinal chemical and botanical products.
Companies and filings in the Manufacture of pharmaceuticals, medicinal chemical and botanical products industry, within the Manufacturing sector.
2,118
Companies
20
New filings
Latest filings
Live feed| Company | Document | Date | Actions |
|---|---|---|---|
|
Regulatory Filings
8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
|
May 04 | ||
|
Regulatory Filings
8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)
|
May 04 | ||
|
Regulatory Filings
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 26, 2026
|
May 04 | ||
|
Foreign Filer Report
6-K - Polyrizon Ltd. (0001893645) (Filer)
|
May 04 | ||
|
Regulatory Filings
Allegato 3F
|
May 04 | ||
|
Report Publication Announcement
CALENDAR
|
May 04 | ||
|
Interim / Quarterly Report
10-Q - Organon & Co. (0001821825) (Filer)
|
May 04 | ||
|
Regulatory Filings
NOTICE OF ANNUAL GENERAL MEETING
|
May 04 | ||
|
Regulatory Filings
NEXT DAY DISCLOSURE RETURN
|
May 04 | ||
|
Regulatory Filings
Allegato 3F / Annex 3F
|
May 04 | ||
|
Foreign Filer Report
6-K - Alvotech (0001898416) (Filer)
|
May 04 | ||
|
Regulatory Filings
CIRCULAR OF ANNUAL GENERAL MEETING
|
May 04 | ||
|
Notice of Dividend Amount
Plata dividend - RC17
|
May 04 | ||
|
Notice of Dividend Amount
Plata dividend - RC17
|
May 04 | ||
|
Regulatory Filings
8-K - Assertio Holdings, Inc. (0001808665) (Filer)
|
May 04 | ||
|
Regulatory Filings
8-K - Clene Inc. (0001822791) (Filer)
|
May 04 | ||
|
Regulatory Filings
8-K - Imunon, Inc. (0000749647) (Filer)
|
May 04 | ||
|
Regulatory Filings
8-K - Jaguar Health, Inc. (0001585608) (Filer)
|
May 04 | ||
|
Regulatory Filings
8-K - Kyverna Therapeutics, Inc. (0001994702) (Filer)
|
May 04 | ||
|
Regulatory Filings
8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)
|
May 04 |
Companies in this industry
| Company | Country | Market cap |
|---|---|---|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptogenic herb supplements.
|
Canada | — |
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed cannabis products for legal markets.
|
Canada | — |
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
|
South Korea | — |
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
|
United States of America | $487.14M |
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
|
Switzerland | $6.57M |
|
AD
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical dressings, and wound care.
|
India | — |
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted therapies for addiction.
|
United States of America | $2.34M |
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
|
United States of America | $62.11M |
|
AD
ADIMMUNE CORPORATION
Develops and manufactures human vaccines and biologics for international markets.
|
Taiwan | — |
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
|
Cayman Islands | $434.68M |
|
AD
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemicals for pharmaceutical use.
|
India | — |
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
|
United States of America | $2.57B |
|
AD
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanoparticle technology for targeted drug delivery.
|
Canada | — |
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocular diseases.
|
United States of America | $96.26M |
Advicenne
A specialty pharmaceutical company developing treatments for rare renal diseases.
|
France | $21.45M |
AegirBio AB
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
|
Sweden | $1.65M |
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
|
France | $20.51M |
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications for botulinum toxins.
|
United States of America | $10.95M |
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical products for ophthalmology, neurology, and transplant.
|
Canada | — |
AFC-HD AMS Life Science Co.,Ltd.
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
|
Japan | — |
|
AF
Afexa Life Sciences Inc.
Researched, developed, and manufactured naturally derived OTC supplements for common ailments.
|
Canada | — |
|
AF
AFT Pharmaceuticals Limited
Develops, licenses, and distributes pharmaceuticals across diverse therapeutic areas.
|
New Zealand | — |
|
AF
AFT PHARMACEUTICALS LIMITED
Develops and licenses healthcare products for pain management and eye care globally.
|
Australia | — |
AGENUS INC
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
|
United States of America | $157.05M |
AGIOS PHARMACEUTICALS, INC.
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
|
United States of America | $1.54B |
AHN-GOOK PHARMACEUTICAL Co., Ltd.
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
|
South Korea | — |
AIM Vaccine Co., Ltd.
Develops, manufactures, and commercializes established and advanced vaccines for human use.
|
Hong Kong | — |
AION THERAPEUTIC INC.
Health and wellness company developing AI-driven bio-pharmaceuticals from cannabis and mushrooms.
|
Canada | — |
|
AJ
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics and niche therapeutic areas.
|
India | — |
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
|
United States of America | $6.41M |
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
|
United States of America | $370.19M |
Akeso, Inc.
Global commercial-stage biopharma developing innovative antibody drugs for oncology and immunology.
|
Cayman Islands | — |
|
AK
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and development services.
|
India | — |
|
AL
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specialized placenta extracts.
|
India | — |
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemic diseases.
|
United States of America | $101.11M |
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, processing, and medical clinics.
|
Canada | — |
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
|
United States of America | $262.02M |
|
AL
Alembic Ltd
Vertically integrated producer of generic pharmaceuticals and APIs for global markets.
|
India | — |
|
AL
ALEMBIC PHARMACEUTICALS LIMITED
Vertically integrated developer of generic drugs, APIs, and formulations worldwide.
|
India | — |
|
AL
ALIVUS LIFE SCIENCES LIMITED
Produces and distributes diverse pharmaceuticals across multiple therapeutic categories.
|
India | — |
ALK-Abelló
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
|
Denmark | — |
Alkaloid AD
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
|
North Macedonia | — |
|
AL
Alkem Laboratories Limited
Develops, manufactures, and markets pharmaceutical and nutraceutical products globally.
|
India | — |
Alkermes plc.
Develops and commercializes medicines for central nervous system (CNS) diseases.
|
United States of America | $5.62B |
Allarity Therapeutics, Inc.
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
|
United States of America | $20.56M |
ALLERGY THERAPEUTICS PLC
Immunology company developing aluminum-free vaccines and therapies for allergies.
|
United Kingdom | $870.27M |
Alliance Growers Corp.
Diversified global medical cannabis company focused on CBD export and facility development.
|
Canada | — |
Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
|
Sweden | $14.25M |
|
AL
Allmed Medical Products Co., Ltd
Manufacturer of medical dressings, surgical kits, and disposable healthcare supplies.
|
China | — |
Allogene Therapeutics, Inc.
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
|
United States of America | $794.59M |